Skip to main content
. 2021 Oct 19;9(4):E948–E956. doi: 10.9778/cmajo.20200219

Figure 2:

Figure 2:

Frequency of cost per individual, compared between patients hospitalized with respiratory syncytial virus (RSV) and controls. Costs are represented on a logarithmic scale (2020 Canadian dollars).